Skip to main content
. Author manuscript; available in PMC: 2015 Mar 20.
Published in final edited form as: Toxicology. 2014 Jan 19;317:31–39. doi: 10.1016/j.tox.2014.01.005

Figure 1.

Figure 1

Cross-sectioned representation of the in vitro exposure chamber. The exposure chamber delivers the dry particles to lung cells directly by low air flow (10 mL/min). The in vitro exposure model for particle-bound PBDEs consists of silica particles coated with individual PBDE congeners (BDEs 35, 47, and 99) and a dry powder sprayer connected to a delay chamber and an exposure chamber holding Transwell® inserts.